2OW Stock Overview
Silk Road Medical, Inc operates as a medical device company in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Silk Road Medical, Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.50 |
| 52 Week High | US$39.00 |
| 52 Week Low | US$5.55 |
| Beta | 1.48 |
| 1 Month Change | 13.64% |
| 3 Month Change | 24.11% |
| 1 Year Change | -53.95% |
| 3 Year Change | -58.53% |
| 5 Year Change | n/a |
| Change since IPO | -42.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2OW | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 7.4% | -1.9% | -1.0% |
| 1Y | -53.9% | -10.8% | 2.0% |
Return vs Industry: 2OW underperformed the German Medical Equipment industry which returned -10.8% over the past year.
Return vs Market: 2OW underperformed the German Market which returned 2% over the past year.
Price Volatility
| 2OW volatility | |
|---|---|
| 2OW Average Weekly Movement | 8.3% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2OW has not had significant price volatility in the past 3 months.
Volatility Over Time: 2OW's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 474 | Chas McKhann | silkroadmed.com |
Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure.
Silk Road Medical, Inc Fundamentals Summary
| 2OW fundamental statistics | |
|---|---|
| Market cap | €743.01m |
| Earnings (TTM) | -€49.62m |
| Revenue (TTM) | €172.30m |
4.3x
P/S Ratio-15.0x
P/E RatioIs 2OW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2OW income statement (TTM) | |
|---|---|
| Revenue | US$185.49m |
| Cost of Revenue | US$49.51m |
| Gross Profit | US$135.98m |
| Other Expenses | US$189.40m |
| Earnings | -US$53.42m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.35 |
| Gross Margin | 73.31% |
| Net Profit Margin | -28.80% |
| Debt/Equity Ratio | 51.5% |
How did 2OW perform over the long term?
See historical performance and comparison